Its foundries are utilized by Broadcom, AMD, Qualcomm, Apple, and other companies to make chips that power various AI applications, such as data centers, smartphones, and personal computers (PCs). So, ...

Looking ahead to 2030, our model projects NVDA could trade at an average price of $248.82, with a potential range between $186.62 and $311.03. This represents a potential 36.1% return from today's ...

Pagaya Techs (NASDAQ:PGY) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives ...

AppLovin is the best-of-breed digital advertising company, boasting high top-line growth and pristine EBITDA/FCF margins, ...

Abstract: Selecting the best smartphone can be challenging due to the wide range of models available on the market. This study shows how the machine learning models can predict mobile phone prices ...

In modern financial markets, recognizing trends is essential for investors seeking profits. Stock databases, or Stock DB, organize vast amounts of market data efficiently. These platforms combine ...

Quick Summary ChatGPT thinks Cloudlfare stock could trade lower over the next 60 days, projecting an average price around $168 by mid-April. Investors looking to trade the stock can build exposure ...

Meta Platforms Inc.’s (NASDAQ: META) AI push was a key driver for the company in 2025, with integrations coming across numerous platforms, which is fueling engagement and increasing ad sales. Despite ...

Palantir has delivered triple-digit returns for shareholders in three consecutive years. Independent research firms rank Palantir as a leader in AI decisioning platforms and AI source-to-pay software.

This article contains references to products from our advertisers and/or partners, and we may receive compensation when you click on links to products and services Precious metal investing has always ...

Nvidia is the world's largest company, with a market cap of $4.5 trillion. The company has a number of catalysts that could fuel further valuation expansion thanks to rising infrastructure spending.

Abivax has a potential transformative medicine in its pipeline that is attracting attention from other drugmakers. If the biotech gets acquired this year, its shares could soar. 10 stocks we like ...